SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...

Columnist Desiree Lama is glad to see daylight saving time come to an end, as the darker evenings better suit her needs with ...

Ultraviolet light therapy may help reduce inflammation and disease severity in people with MS, according to data from a small ...

Levels of antibodies targeting the Epstein-Barr virus are not associated with disease activity among multiple sclerosis ...

People with MS of all ages and genders consistently report reduced quality of life relative to the general population, a ...

A high-carbohydrate diet significantly increases the risk of MS, particularly for women and younger than 60, a study found.

Guest writer Brian Howard faced numerous difficulties after being diagnosed with MS. Even so, people can still lean on him ...

A third of adults live with chronic health issues like multiple sclerosis, but in most cases, they are not obvious to observers, data show.

Enrollment is complete for the randomized part of ENHANCE, a Phase 3 trial testing a new dosing schedule for Briumvi in ...

Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...

People with multiple sclerosis (MS) have altered levels of several key bacteria in the mouth, a new study reports.

Columnist Ben Hofmeister, who lives with MS, shares his experiences coping with the daily challenges of bladder and bowel symptoms.